Background Extracorporeal membrane oxygenation (ECMO) is used for severe lung and/or heart failure in intensive care units (ICU). The Prince Charles Hospital (TPCH) has one of the largest ECMO units in Australia. Its use rapidly increased during the H1N1 (“swine flu”) pandemic and an increase in pedal complications resulted. The relationship between ECMO and pedal complications has been describ...

Refractory cardiac arrhythmia, which has a poor response to defibrillation and antiarrhythmia medication, is a complicated problem for clinical physicians during resuscitation. Extracorporeal membrane oxygenation (ECMO) may be used to sustain life in this situation. ECMO is useful for cardiopulmonary resuscitation among patients suffering from cardiac arrest; the use of ECMO in this context is ...

BACKGROUND Extracorporeal membrane oxygenation (ECMO) has been used to support cardiorespiratory function during pediatric cardiopulmonary resuscitation (CPR). We report on outcomes and predictors of in-hospital mortality after ECMO used to support CPR (E-CPR). METHODS AND RESULTS Outcomes for patients aged <18 years using E-CPR were analyzed with data from the Extracorporeal Life Support Org...

Veno-Arterial extracorporeal (VA ECMO) provides temporary mechanical support to the patient with cardiac and/or respiratory failure in cases of cardiogenic shock or heart failure [1-3]. VA ECMO essentially decreases cardiac work and reduces oxygen consumption while providing sufficient organ perfusion. ECMO is a bridge to recovery, left ventricular assist device (LVAD) implantation or eventual ...

Extracorporeal membrane oxygenation (ECMO) is a technique for providing cardiac and/or pulmonary support. Many hospitals worldwide practice ECMO at some time, yet few centers are able to offer a portable ECMO service, with the United Kingdom being of no exception. We describe the first reported successful ground transfer of a 22-kg girl with suspected myocarditis, supported by veno-arterial ECM...

Extracorporeal membrane oxygenation (ECMO) for respiratory failure was reviewed. ECMO progressed from laboratory research to initial clinical trials in 1972. Following a decade of clinical research, ECMO is now standard treatment for neonatal respiratory failure refractory to conventional pulmonary support techniques worldwide. The application of neonatal ECMO has been extended with improved ou...

The use of extracorporeal membrane oxygenation (ECMO) has increased after 2009 pandemic H1N1 infection, and the ECMO related complications have also increased. Especially mechanical vessel injury due to catheter cannulation seems less frequency than other complications, but there is a risk of hemorrhagic shock requiring caution. We experienced a case of early detection of iliac vein injury by b...

When patients with severe respiratory failure are treated with venovenous extracorporeal membrane oxygenation (VV-ECMO), severe pulmonary hypertension due to right ventricular (RV) failure is possible. This is a serious complication that requires immediate therapeutic intervention. We report an extraordinary experience of additional venoarterial extracorporeal membrane oxygenation (VA-ECMO) sup...

BACKGROUND In the emergency department (ED), extracorporeal membrane oxygenation (ECMO) can be used as a rescue treatment modality for patients with refractory circulatory and/or respiratory failure. Serious consideration must be given to the indication, and the PRESERVE and RESP scores for mortality have been investigated. However these scores were validated to predict survival in patients who...

BACKGROUND Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an effective technique for providing emergency mechanical circulatory support for patients with cardiogenic shock. VA-ECMO enables a rapid restoration of global systemic organ perfusion, but it has not been found to always show a parallel improvement in the microcirculation. We hypothesized in this study that the response...